Should Lilly Stock? Here's My Honest Take on Eli Lilly
Eli Lilly sits at the center of the healthcare toolkit for many investors. This article breaks down the case for and ...
This brief describes typical assets that make up an equal weighted index and how diverse holdings contribute to balanced exposure and performance.
17,287 articlesEli Lilly sits at the center of the healthcare toolkit for many investors. This article breaks down the case for and ...
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Three ETFs with yields above 10% are drawing attention in March 2026, each using a different mechanism to pay out hig...
As Commvault shares dive, a fresh $19.8 million stake signals confidence from a hedge fund with a plan. Here's how to...
A big data-center lease helped Applied Digital stock soar, signaling strong demand for AI infrastructure. Learn what ...
A sharp drop in a space-focused stock can spark questions about risk and timing. This guide breaks down the real reas...
As 2026 unfolds, investors face a choice between two very different travel giants. One leans on software and hosts to...
A batch of midweek analyst notes lifts several big names, steering markets higher as investors weigh price targets, e...
As Madrigal prepares to report its 2025 earnings, investors weigh pipeline progress, cash runway, and milestones ahea...
Dive into cadre holdings (cdre) 2025 with a clear, practical lens. This guide translates earnings chatter into real-w...
An executive sale of shares often sparks questions. This article unpacks what cheesecake factory sells $328000 means ...
When a Klaviyo director sold over 9,000 shares, it sparked questions about timing, risk, and company confidence. This...